Abstract
Background: The effects of combined tiotropium/olodaterol (Respimat®) on airflow obstruction, lung hyperinflation, exercise tolerance, and exacerbation in chronic obstructive pulmonary disease (COPD) have been reported. However, the effects on dynamic lung hyperinflation (DLH) have not been reported. We have developed a dedicated spirometer (Spiro Sift SP-390 Rhino) to measure DLH using the metronome-paced incremental hyperventilation (MPIH) method. Aims and Objectives: This study was performed to examine whether combined tiotropium/olodaterol (Respimat®) can improve DLH assessed by the MPIH method using the dedicated spirometer, whether it can improve exercised performance in COPD. Methods: Thirty-three patients with mild to severe stable COPD were included in the study. This was a comparative study before and 8 weeks after treatment with combined tiotropium/olodaterol 5/5 μg (Respimat®) once a day. DLH was assessed by the MPIH method, with incremental hyperventilation of 30-s stepwise increments starting at the resting respiration rate (RR) and increasing to RR of 20, 30, and finally 40 using a Spiro Sift SP-390 Rhino spirometer. The primary outcome was the decrease in inspiratory capacity (IC) from that at the resting RR. Results: The decreases in IC following hyperventilation were significantly reduced after treatment. In addition, FEV1, CAT (COPD assessment test) score, and 6-minute walking distance were also significantly improved. Conclusions: Combined tiotropium/olodaterol (Respimat®) may improve DLH and exercise performance in addition to increasing FEV1 and health status in COPD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.